Accelerate@Babraham supports early-stage life sciences ventures within the Babraham Research Campus’ community More: Kidney Research UK pledges support to Accelerate@Babraham initiative Source: News
read moreCureVac’s CVnCoV is currently being investigated in a randomised, placebo-controlled Phase IIb/III clinical trial More: CureVac’s COVID-19 vaccine begins rolling review with EMA Source: News
read moreCDK4 & 6 inhibitor has been available as part of a Cancer Drugs Fund (CDF) managed access agreement More: NICE rejects Lilly’s Verzenios for advanced breast cancer Source: News
read morePeople aged 65 to 69 and the clinically vulnerable will be offered the jab from today More: UK expands COVID-19 vaccinations to over-65s after 15 million receive first dose Source: News
read moreASCO GU: Merck, Eisai turn up the heat in kidney cancer with Keytruda-Lenvima survival data chelfand Sat, 02/13/2021 – 12:55 More: ASCO GU: Merck, Eisai turn up the heat in kidney cancer with Keytruda-Lenvima survival data Source: fierce
read moreMallinckrodt faces regulatory delay as COVID-19 restrictions continue to upend FDA’s inspection schedule fkansteiner Fri, 02/12/2021 – 11:24 More: Mallinckrodt faces regulatory delay as COVID-19 restrictions continue to upend FDA's inspection schedule Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals